Dapagliflozin vs Fluorodopa F 18
Dapagliflozin vs Fluorodopa F 18: Overview
This comparison examines the pharmacological differences between Dapagliflozin and Fluorodopa F 18.
Mechanism of Action
Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.
Pharmacokinetics
Half-life: Dapagliflozin β 12.9 hours.
Chemical Properties
Molecular Formula: Dapagliflozin β C21H25ClO6.
Molecular Weight: Dapagliflozin β 408.8730 g/mol.
Type: Dapagliflozin β Small molecule; Fluorodopa F 18 β Small molecule.